NetworkNewsBreaks

MondayAug 12, 2024 11:27 am

NetworkNewsBreaks – SuperCom Ltd. (NASDAQ: SPCB) Schedules Q2 2024 Financial Results Earnings Call

SuperCom (NASDAQ: SPCB), a global provider of secured solutions for the e-government, Internet of Things (“IoT”) and cybersecurity sectors, has scheduled a conference call and webcast to discuss its financial results for the second quarter 2024. The call is slated to begin at 10 a.m. ET on Aug. 15, 2024. The company plans on releasing its financial results prior to the call. During the call, SuperCom management will provide an overview of the report and answer questions. Those wanting to access the call can dial 888-506-0062 (toll free in the U.S.), 1-809-423-853 (in Israel), or 973-528-0011 (international), then use the…

Continue Reading

MondayAug 12, 2024 11:07 am

NetworkNewsBreaks – Local and Federal Lawmakers Support D-Wave Quantum Inc. (NYSE: QBTS), Davidson Technologies Partnership for National Defense Efforts

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, and Davidson Technologies received strong support from local and federal lawmakers at the Space and Missile Defense Symposium that was held on August 6th for bringing advanced quantum computing to Alabama. Huntsville Mayor Tommy Battle joined D-Wave and Davidson to emphasize the strategic significance of placing a D-Wave quantum computer at Davidson’s new global headquarters in Huntsville, AL. D-Wave’s state-of-the-art Advantage™ quantum computing system is expected to be installed at Davidson’s headquarters in 2025, with this forthcoming installation marking a major milestone in the country’s…

Continue Reading

MondayAug 12, 2024 10:57 am

NetworkNewsBreaks – HealthLynked Corp. (HLYK) Partners with RxSpark to Provide Integrated Solution for Medication Management

HealthLynked (OTCQB: HLYK), a trailblazer in healthcare technology, today announced a strategic partnership with RxSpark, a platform dedicated to providing affordable prescription medications and healthcare services. According to the announcement, this partnership will enhance the patient’s experience by integrating HealthLynked’s advanced healthcare network with RxSpark’s pharmacy discounts and prescription price comparison tool. Through this exciting integration, HealthLynked members can find savings of up to 90% off their medications, easily manage their prescriptions, and ensure timely access to necessary medications. Key benefits include enhanced prescription management, improved access to affordable medications, streamlined healthcare experience, and cost savings for patients. “At HealthLynked,…

Continue Reading

MondayAug 12, 2024 10:42 am

NetworkNewsBreaks – Upstream Lists Advantages of Trading Powered by Blockchain Tech

Upstream, a MERJ Exchange stock market and global trading app, is powered by blockchain technology, which is self-sufficient and operates continuously. That model means that stock markets could operate 24/7 with instantaneous settlement, which changes the landscape, particularly during market sell-offs. The advantages of that were discussed in a recent Upstream article. The article noted that “this past Monday morning, the Dow Jones Industrial Average fell more than 1,000 points. The Nikkei 225, an index of leading stocks in Tokyo, closed down 5.8% Friday, and then 12.4% on Monday.” The article observed that because of traditional stock-trading hours, an entire…

Continue Reading

MondayAug 12, 2024 9:12 am

NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Shareholders Approve Plans for Share Consolidation, Name Change

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is planning to consolidate its issued and outstanding class A multiple voting shares and class B subordinate voting shares. The company also has announced a planned name change to Quantum BioPharma Ltd, with a new trading symbol of QNTM. The consolidation, which is part of the company’s efforts to regain compliance with NASDAQ’s minimum bid price, and name change are subject to approval by the NASDAQ exchange; if approved, the changes will be effective Aug. 15, 2024. These…

Continue Reading

MondayAug 12, 2024 9:00 am

NetworkNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Lead Candidate Passes FDA-Required Testing, Does Not Cause Cell-Division Damage

Oragenics (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, announced that its lead candidate for treating concussion, ONP-002, does not cause DNA damage and genotoxicity in an animal model. According to the announcement, the company completed a study evaluating ONP-002, a new chemical entity (“NCE”) designed to target the brain through delivery into the nasal cavity and onward to the brain. Testing on cells and animals to ensure a substance does not cause damage affecting cell division is required by the U.S. Food and Drug Administration prior to conducting a clinical…

Continue Reading

FridayAug 09, 2024 2:18 pm

NetworkNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) Releases Q2 2024 Financial Results Showing ‘Traction on All Fronts’

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, today announced financial results for the second quarter of fiscal 2024 (“Q2 2024”) ended June 30, 2024, and provided recent business and technical highlights. The company’s Q2 2024 revenue was $2.2 million, an increase of 28% from Q2 2023 revenue of $1.7 million, while Q2 2024 Bookings (*) were $2.7 million, a 6% increase from Q2 2023 Bookings of $2.5 million. According to the announcement, this represents D-Wave’s ninth consecutive quarter of year-over-year growth in quarterly Bookings. In addition, GAAP gross profit for Q2 2024…

Continue Reading

FridayAug 09, 2024 2:07 pm

NetworkNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Reports on Status of New Product, Investment in Celly Nutrition Corp.

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is providing a status report on its investment in Celly Nutrition Corp. A privately held Canadian company, Celly Nu is launching an innovative beverage product designed to assist in expediting alcohol metabolism and faster recovery from alcohol consumption. According to the update, Celly Nu has announced the imminent launch of its revolutionary, great-tasting, scientifically backed product, unbuzzd(TM). The product will be available in 3-pack or 18-pack options, and the compact packages can easily be carried in a pocket…

Continue Reading

FridayAug 09, 2024 2:00 pm

NetworkNewsBreaks – Expion360 Inc. (NASDAQ: XPON) Closes on Underwritten Public Offering Estimated at $10M Value

Expion360 (NASDAQ: XPON), a lithium-ion battery power storage solutions company, has closed on a firm commitment underwritten public offering. According to the announcement, the offering is estimated to result in $10 million gross proceeds before standard deductions. The offering is comprised of 50,000,000 common units or prefunded units, with each unit consisting of one share of XPON common stock or one prefunded warrant to purchase one share of common stock, two Series A warrants each to purchase one share of common stock, and one Series B warrant to purchase such number of shares of common stock as determined in the…

Continue Reading

FridayAug 09, 2024 1:57 pm

NetworkNewsBreaks – Alphabet Inc. (NASDAQ: GOOGL) Faces Antitrust Scrutiny Amid Market Dominance

Alphabet (NASDAQ: GOOGL, GOOG), the parent company of Google, is currently facing a challenging period, with antitrust scrutiny at the forefront of its concerns. Despite the complexities surrounding the antitrust ruling, experts from Barron’s suggest that Google’s market dominance is unlikely to be significantly impacted by the label of being a monopolist. However, it’s important to note that other risks loom large, potentially threatening the tech giant’s position. The recent performance of Alphabet Inc.’s stock reflects the company’s current challenges and investor sentiment. With a closing price of $159.89, down $2.15 or -1.32%, the market is reacting to the ongoing developments. The stock’s movement…

Continue Reading